Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Sowmya Kaur is the Executive Vice President and BU Head Clinical APAC/Russia at Navitas Life Sciences with a successful track record of building and leading Clinical Development engagements across Emerging Markets with successful delivery of portfolio of projects.
Articles by Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
2
Applying AI to Automate Workflows Without Disrupting Sites
3
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5